219 related articles for article (PubMed ID: 33729832)
1. Long QT Syndrome
Feng L; Zhang J; Lee C; Kim G; Liu F; Petersen AJ; Lim E; Anderson CL; Orland KM; Robertson GA; Eckhardt LL; January CT; Kamp TJ
Circ Arrhythm Electrophysiol; 2021 Apr; 14(4):e009343. PubMed ID: 33729832
[TBL] [Abstract][Full Text] [Related]
2. Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
Caballero R; Utrilla RG; Amorós I; Matamoros M; Pérez-Hernández M; Tinaquero D; Alfayate S; Nieto-Marín P; Guerrero-Serna G; Liu QH; Ramos-Mondragón R; Ponce-Balbuena D; Herron T; Campbell KF; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Delpón E; Tamargo J
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E416-E425. PubMed ID: 28049825
[TBL] [Abstract][Full Text] [Related]
3. Mouse ERG K(+) channel clones reveal differences in protein trafficking and function.
Lin EC; Moungey BM; Lim E; Concannon SP; Anderson CL; Kyle JW; Makielski JC; Balijepalli SY; January CT
J Am Heart Assoc; 2014 Dec; 3(6):e001491. PubMed ID: 25497881
[TBL] [Abstract][Full Text] [Related]
4. Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome.
Bellin M; Casini S; Davis RP; D'Aniello C; Haas J; Ward-van Oostwaard D; Tertoolen LG; Jung CB; Elliott DA; Welling A; Laugwitz KL; Moretti A; Mummery CL
EMBO J; 2013 Dec; 32(24):3161-75. PubMed ID: 24213244
[TBL] [Abstract][Full Text] [Related]
5. Modelling the long QT syndrome with induced pluripotent stem cells.
Itzhaki I; Maizels L; Huber I; Zwi-Dantsis L; Caspi O; Winterstern A; Feldman O; Gepstein A; Arbel G; Hammerman H; Boulos M; Gepstein L
Nature; 2011 Mar; 471(7337):225-9. PubMed ID: 21240260
[TBL] [Abstract][Full Text] [Related]
6. Promise and Potential Peril With Lumacaftor for the Trafficking Defective Type 2 Long-QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes.
O'Hare BJ; John Kim CS; Hamrick SK; Ye D; Tester DJ; Ackerman MJ
Circ Genom Precis Med; 2020 Oct; 13(5):466-475. PubMed ID: 32940533
[TBL] [Abstract][Full Text] [Related]
7. Eag Domains Regulate LQT Mutant hERG Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Liu QN; Trudeau MC
PLoS One; 2015; 10(4):e0123951. PubMed ID: 25923442
[TBL] [Abstract][Full Text] [Related]
8. Translation reinitiation in c.453delC frameshift mutation of KCNH2 producing functional hERG K+ channels with mild dominant negative effect in the heterozygote patient-derived iPSC cardiomyocytes.
Park NK; Park SJ; Park YG; Moon SH; Woo J; Kim HJ; Kim SJ; Choi SW
Hum Mol Genet; 2024 Jan; 33(2):110-121. PubMed ID: 37769355
[TBL] [Abstract][Full Text] [Related]
9. Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome.
Jouni M; Si-Tayeb K; Es-Salah-Lamoureux Z; Latypova X; Champon B; Caillaud A; Rungoat A; Charpentier F; Loussouarn G; Baró I; Zibara K; Lemarchand P; Gaborit N
J Am Heart Assoc; 2015 Sep; 4(9):e002159. PubMed ID: 26330336
[TBL] [Abstract][Full Text] [Related]
10. hERG1a N-terminal eag domain-containing polypeptides regulate homomeric hERG1b and heteromeric hERG1a/hERG1b channels: a possible mechanism for long QT syndrome.
Trudeau MC; Leung LM; Roti ER; Robertson GA
J Gen Physiol; 2011 Dec; 138(6):581-92. PubMed ID: 22124116
[TBL] [Abstract][Full Text] [Related]
11. hERG1a and hERG1b potassium channel subunits directly interact and preferentially form heteromeric channels.
McNally BA; Pendon ZD; Trudeau MC
J Biol Chem; 2017 Dec; 292(52):21548-21557. PubMed ID: 29089383
[TBL] [Abstract][Full Text] [Related]
12. Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.
Matsa E; Dixon JE; Medway C; Georgiou O; Patel MJ; Morgan K; Kemp PJ; Staniforth A; Mellor I; Denning C
Eur Heart J; 2014 Apr; 35(16):1078-87. PubMed ID: 23470493
[TBL] [Abstract][Full Text] [Related]
13. The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2.
Mura M; Mehta A; Ramachandra CJ; Zappatore R; Pisano F; Ciuffreda MC; Barbaccia V; Crotti L; Schwartz PJ; Shim W; Gnecchi M
Int J Cardiol; 2017 Aug; 240():367-371. PubMed ID: 28433559
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor.
McBride CM; Smith AM; Smith JL; Reloj AR; Velasco EJ; Powell J; Elayi CS; Bartos DC; Burgess DE; Delisle BP
J Membr Biol; 2013 May; 246(5):355-64. PubMed ID: 23546015
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for the Study of Variant Pathogenicity: Validation of a
Gélinas R; El Khoury N; Chaix MA; Beauchamp C; Alikashani A; Ethier N; Boucher G; Villeneuve L; Robb L; Latour F; Mondesert B; Rivard L; Goyette P; Talajic M; Fiset C; Rioux JD
Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29021306
[TBL] [Abstract][Full Text] [Related]
16. hERG 1a LQT2 C-terminus truncation mutants display hERG 1b-dependent dominant negative mechanisms.
Puckerin A; Aromolaran KA; Chang DD; Zukin RS; Colecraft HM; Boutjdir M; Aromolaran AS
Heart Rhythm; 2016 May; 13(5):1121-1130. PubMed ID: 26775140
[TBL] [Abstract][Full Text] [Related]
17. Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.
Mihic A; Chauhan VS; Gao X; Oudit GY; Tsushima RG
PLoS One; 2011 Mar; 6(3):e18273. PubMed ID: 21483829
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of loss of Kv11.1 K+ current in mutant T421M-Kv11.1-expressing rat ventricular myocytes: interaction of trafficking and gating.
Balijepalli SY; Lim E; Concannon SP; Chew CL; Holzem KE; Tester DJ; Ackerman MJ; Delisle BP; Balijepalli RC; January CT
Circulation; 2012 Dec; 126(24):2809-18. PubMed ID: 23136156
[TBL] [Abstract][Full Text] [Related]
19. Modeling long-QT syndromes with iPS cells.
Sinnecker D; Goedel A; Dorn T; Dirschinger RJ; Moretti A; Laugwitz KL
J Cardiovasc Transl Res; 2013 Feb; 6(1):31-6. PubMed ID: 23076501
[TBL] [Abstract][Full Text] [Related]
20. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture.
Lahti AL; Kujala VJ; Chapman H; Koivisto AP; Pekkanen-Mattila M; Kerkelä E; Hyttinen J; Kontula K; Swan H; Conklin BR; Yamanaka S; Silvennoinen O; Aalto-Setälä K
Dis Model Mech; 2012 Mar; 5(2):220-30. PubMed ID: 22052944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
